home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Tumor Burden and Clinical Benefit Assessment in Immunotherapy Clinical Trials

 
  August 16, 2016  
     
 
Xtalks Life Science Webinars, Online
2016-09-19


This webinar will give an overview of endpoint assessment as it relates to RECIST, irRC, and clinical benefit in the setting of cancer immunotherapy.
 
 
Organized by: Xtalks Life Science Webinars
Invited Speakers:
  • Klaus Noever, MD, Senior Director of Medical Affairs, WorldCare Clinical, LLC
  • Ryan J. Sullivan, MD, Assistant in Medicine, MGH Cancer Center, Massachusetts General Hospital, and Assistant Professor, Medicine, Harvard Medical School
 
Deadline for Abstracts: 2016-09-19
 
Registration: FREE
E-mail: ajuurinen@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.